Famisanar begins transition process in medication delivery: everything its members need to know

The termination of the contract between Droguerías Colsubsidio and EPS Famisanar for the delivery of medications became effective on August 1, 2025.

In a press release, the EPS announced that, starting that day and continuing through August 31, it will undergo a transition process to new pharmaceutical managers who will dispense all medications starting September 1, 2025.

During this period, Colsubsidio Drugstores will continue to provide a specific list of capitated medications until August 31. The complete list of these drugs can be found at the following link: https://cutt.ly/ArPcW7fP

"If the medication is not on the list, it can now be ordered from the new pharmacy operator assigned to the region," the statement said.

To claim medications not on the list, explains the EPS, and to find out their new delivery point, members must update their medication authorization through the following channels or in person:

- Famisanar online: https://enlinea.famisanar.com.co/Portal/home.jspx?_gl=1*188fi57*_gcl_au*MjE0Mjc4NjU3LjE3NTE5MDE5NTk

- WhatsApp Camila: +57 300 6438831.

- Video call: https://www.famisanar.com.co/agendamiento-videollamada-turno-oficina

From September 1, 2025, medications will be dispensed exclusively by new regional pharmaceutical managers:

- Tunja, Chiquinquirá and Paipa (Boyacá): Discolmets

- Soacha, Fusagasugá, Funza, Girardot, Cajicá, La Mesa - (Cundinamarca) and Ibagué (Tolima): Marcazsalud

Villavicencio (Goal): Sikuany

The termination of the contract between Droguerías Colsubsidio and EPS Famisanar for the delivery of medications has raised alarm among members of this insurance company, which has been under intervention by the National Health Superintendency for over a year.

While Famisanar maintains that the contract termination was due to failures in drug dispensing, Colsubsidio has emphasized that the decision comes amid a multi-million-dollar debt exceeding 781 billion pesos, of which 208 billion corresponds to drug dispensing and 572 billion to medical services provided in its network of clinics and outpatient centers.

In July, in an interview with EL TIEMPO, Colsubsidio president Luis Carlos Arango stated that although Famisanar has reported payments of more than 2 billion pesos since September 2023, it has not been clear about the outstanding obligations.

"They say how much they've paid, but not how much they owe," he says. Arango warns that the situation has become unsustainable, to the point that Colsubsidio has had to continue delivering medications with its own resources due to the EPS's nonpayment.

Although the contract will end on August 1, Colsubsidio will continue providing the medication delivery service until August 31, in a transition phase to reduce the impact on the more than 1.6 million Famisanar members it served, Arango said. However, the executive warns that the new model with four regional operators could create logistical complications.